Science: Biology

Neil Bush Joins Board of Directors for Greffex, a Pioneering Vaccine Company

Leave a comment


Neil Bush

“Neil Bush understands the need for a global perspective to make an impactin a post pandemic world,” said Co-Chairman John Price, also Presidentand CEO of Greffex. Mr. Bush will serve as an independentdirector of the company.


HOUSTON (PRWEB)

Greffex, a pioneering vaccine and gene therapy company based in Houston, Texas, welcomes Mr. Neil Bush to its Board of Directors.

“Neil understands the need for a global perspective to make an impact in a post pandemic world,” said Co-Chairman John Price, also President and CEO of Greffex. Mr. Bush will serve as an independent

director of the company.

“The Greffex board is excited to have Neil as a part of the team. He has vast international experience with a history of knowing, and advising, the most powerful companies and leaders in the world. Neil will be a huge asset to drive our future growth and enable Greffex’s mission to create innovative therapies that protect and heal mankind,” said Price.

Bush is an international businessman who operates through Neil Bush Global Advisers. He is Chairman of Singhaiyi, a Singapore publicly listed company; Co-Chairman of CIIC, a property development business in China; and, Chairman of A&A Consulting, a global platform that provides bridging services between the United States and Asia in health care, education, and technology in the USA.

“I can think of no better way to serve”, said Bush. “I am very excited to join the Greffex board to help advance the critically important work of implementing one of the world’s first universal vaccine platform to address the Covid-19 pandemic, and save lives, while enhancing the world’s capability to quickly respond to future pandemics. Based on testimonials of experts I am confident that Greffex will be successful — we must be successful!”

Mr. Bush also serves as Chairman of the Points of Light Board of Directors and Chairman of the Advisory Board of the Bush School of Government and Public Service. In these roles, Mr. Bush expands his father’s vision of inspiring, equipping and mobilizing volunteers to address serious social issues and training future generations of public and nonprofit leaders.

Mr. Bush will join a Board that includes:

John P Price, Greffex Co-Chairman, President and CEO

Uwe D. Staerz, M.D., Ph.D., Greffex Chief Scientist & Co-Chairman

Robert A. Eckels JD, Greffex Executive Vice President & General Counsel. Past Harris County Texas Judge

William S. Connolly, Greffex Executive Vice President

Sir Walter Bodmer, PhD, FRS, Head, Cancer & Immunogenetics Laboratory, University of Oxford

Chase Untermeyer, Former US Ambassador to Qatar

Jehan A. Al-Meer, MSC, PhD, MPA, MBA, Founder and CEO of Innovation Capital Qatar

R. Phil Zobrist, Real Estate Management and Development Entrepreneur

John D. White, JD., Chairman emeritus, Texas A&M University System Board of Regents

Greffex, a leading genetic engineering company, is a leader in developing a plug and play vaccine platform that delivers unprecedented time-to-market, cost efficiency, efficacy and safety through the use of proprietary clean viral vectors.

Share article on social media or email:

Leave a Reply